文献速递糖尿病垂体与肾上腺疾病

无糖尿病的糖尿病酮症酸中毒

Diabetic Ketoacidosis Without Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2016-09-16

报告一例39岁尼日利亚女性B型胰岛素抵抗综合征病例,表现为严重体重下降、重度糖尿病酮症酸中毒及严重胰岛素抵抗,需大剂量外源性胰岛素。合并系统性红斑狼疮,经利妥昔单抗联合脉冲地塞米松免疫调节治疗4个月后达血糖正常缓解,1年后维持硫唑嘌呤治疗仍无需外源性胰岛素。

要点

  • B型胰岛素抵抗综合征由抗胰岛素受体自身抗体引起,可表现为严重胰岛素抵抗伴高血糖或低血糖。
  • 该综合征可并发重度糖尿病酮症酸中毒,尽管使用大剂量外源性胰岛素。
  • 利妥昔单抗联合地塞米松后序贯硫唑嘌呤维持治疗1年,可使患者达血糖正常缓解并脱离外源性胰岛素。

核心结论

  • B型胰岛素抵抗综合征可并发重度糖尿病酮症酸中毒,即使使用大剂量外源性胰岛素。
  • 利妥昔单抗联合地塞米松后序贯硫唑嘌呤维持治疗1年,是管理B型胰岛素抵抗综合征的有效治疗方法。

研究设计与样本

  • 病例报告:一名39岁尼日利亚女性B型胰岛素抵抗综合征患者。

主要发现

  • 患者表现为显著体重下降、重度糖尿病酮症酸中毒和严重胰岛素抵抗,需大剂量外源性胰岛素。
  • 诊断为系统性红斑狼疮和B型胰岛素抵抗综合征。
  • 经利妥昔单抗和脉冲剂量地塞米松免疫调节治疗4个月后达血糖正常缓解。
  • 1年后维持硫唑嘌呤治疗,仍无需外源性胰岛素。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Type B insulin resistance syndrome is a rare disease that occurs due to the development of autoantibodies to the insulin receptor and can result in either severe insulin resistance and hyperglycemia or, conversely, hypoglycemia. Diabetes mellitus is often severe, usually transient, and poorly responsive to exogenous insulin. Diabetic ketoacidosis is an unusual consequence of this most severe form of transient diabetes mellitus. CASE DESCRIPTION: A 39-year-old Nigerian woman presented with significant weight loss, severe diabetic ketoacidosis, and severe insulin resistance requiring massive doses of exogenous insulin. She was diagnosed with systemic lupus erythematosus and type B insulin resistance syndrome. She was treated by immunomodulation with rituximab and pulse dose dexamethasone, and she entered euglycemic remission after 4 months of treatment. She remains independent of exogenous insulin 1 year later on maintenance azathioprine therapy. CONCLUSION: We report a case of severe type B insulin resistance syndrome complicated by severe diabetic ketoacidosis soon after the initial diagnosis of diabetes, despite large doses of exogenous insulin therapy. Our patient achieved euglycemic remission after combination immunomodulation. This case illustrates the severe catabolic state that may occur with high anti-insulin receptor antibody titers and that combination therapy with rituximab and dexamethasone, followed by maintenance azathioprine therapy for 1 year, is an effective treatment approach for the management of type B insulin resistance syndrome.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Willard D, Upadhyay J, Kim C, et al. Diabetic Ketoacidosis Without Diabetes. J Clin Endocrinol Metab. 2016. PMID: 27636019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。